Hypertension in Pregnancy

Papers
(The median citation count of Hypertension in Pregnancy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial25
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China25
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates16
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients13
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials12
Correction12
Statement of Retraction: Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section11
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk11
WGCNA combined with machine learning for analysis of diagnostic markers of preeclampsia associated with the hedgehog signaling pathway10
Intraabdominal pressure as a marker for physiologic and pathologic processes in pregnancy10
Pre-eclampsia screening with maternal risk factors and ophthalmic Doppler artery: a systematic review10
Targeting oxidative stress in preeclampsia8
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio7
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy7
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies6
Umbilical cord-derived exosomal miR−548 is involved in driving preeclampsia pathogenesis by Inhibiting trophoblast cells invasion6
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy5
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis5
A nomogram for preeclampsia risk prediction in the first trimester: a nested case-control study5
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter4
SII serves as an independent diagnostic indicator for GDM and is regulated by placental 5-HT/NF-κB signaling4
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study4
The obesity associated FTO gene polymorphism and the risk of preeclampsia in Iranian women: A case–control study3
Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis3
The role of early second trimester maternal serum cadherin-11 levels in the prediction of preeclampsia3
Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?3
Examining the relationship between maternal preeclampsia and autism spectrum disorder in childhood3
Association of systemic inflammatory response index with severity of preeclampsia3
Hypertensive disorders of pregnancy after multifetal pregnancy reduction: a systematic review and meta-analysis2
Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks2
Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia2
Impact of behavioral phenotypes on response to a digital intervention to improve physical activity among postpartum individuals with hypertensive disorders of pregnancy2
Integrated bioinformatics analysis identifies neutrophils and villous cytotrophoblasts infiltration characterized by BLC6 upregulation as associated with the co-occurrence of gestational diabetes mell2
Endoplasmic reticulum stress-related genes drive M1 macrophage polarization in preeclampsia via modulating metabolic reprogramming: a bioinformatic study2
Urine and serum L-type fatty acid-binding protein levels in preeclampsia: a prospective cohort study on maternal deterioration prediction2
Cardiorespiratory fitness in women after severe pre-eclampsia2
Predicting intensive care need in women with preeclampsia using machine learning – a pilot study2
Relationship between the hemodynamic profile and resistant hypertension in pregnant patients with hypertensive crisis2
Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?2
Novel molecular strategies for preeclampsia management: a pathophysiological and therapeutic perspective2
Associations between extreme temperature exposure and hypertensive disorders in pregnancy: a systematic review and meta-analysis1
Evaluation of a lifestyle intervention for women with gestational diabetes mellitus based on the medical internet of things: a randomized controlled trial with mid-sample verification1
Elevated serum sFlt-1 at 18–20 weeks in advanced maternal age: a key difference from younger pregnancies1
Elevated central blood pressure, NT-proBNP and hs-cTnI in women with maternal complications of hypertensive disorders of pregnancy1
Assessing the causal association of sleep abnormalities with preeclampsia and eclampsia: a Mendelian randomization analysis1
Expression of NEDD4L and ENaC in Urinary Extracellular Vesicles in Pre-eclampsia1
Differences in hematocrit-to-plasma albumin ratio as a predictor of severe maternal morbidity in hypertensive disorders of pregnancy: a retrospective cohort study1
KAT2A promotes NLRP3-mediated trophoblast pyroptosis in preeclampsia by the succinylation1
Comparison of the burden of maternal hypertensive disorders between China and the globe from 1990 to 2023: epidemiological trends and age-period-cohort analysis1
LifeAPP: self-monitoring of blood pressure after preterm preeclampsia: a randomized controlled feasibility trial1
Preeclampsia risk factors in French Guiana: a great heterogeneity among populations and geographic areas1
Long-term outcomes of patients with preeclampsia, a review of the literature1
Expression of Concern: Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: A 3-year observational study1
Maternal deaths due to hypertensive disorders of pregnancy in Brazil from 2012 until 2023: a cross-sectional populational-based study1
Identification of potential circadian rhythm-related hub genes and immune infiltration in preeclampsia through bioinformatics analysis1
The role of continuous analgesia during labor in pregnant women with hypertensive disorders: a comparative study on pain relief, anxiety, depression, and maternal-infant outcomes1
Expression of Concern: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial1
0.29221105575562